Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled trial of bemiparin prophylaxis in hospitalized cirrhotic patients
2015-003866-96Phase 3Completed
- Sponsor
- Angela Puente
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bemiparin in thrombosis, venous thromboembolism (VTE) and portal vein thrombosis (PVT) (2 arms), sponsored by Angela Puente. Primary endpoints: Safety of prophylactic bemiparin, Efficacy for prevention of thrombotic events and 1 more. Started Feb 2016; status: completed.
02
Drugs
bemiparin
03
Conditions
thrombosisvenous thromboembolism (VTE)portal vein thrombosis (PVT)
Beyond the preview
Go deeper on 2015-003866-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003866-96.